Concepedia

Hein Fennema

HF

Statistics

Publications

13

Citations

3.7K

H-Index

12

Active since

2002

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Janssen (Belgium)

München Klinik

Medizinische Hochschule Hannover

MSD (Netherlands)

Hein Fennema is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, hemostasis, and thrombosis.

Publications per year

2002–2021

13

Publications

13

Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19

Jerald Sadoff, Glenda Gray, An Vandebosch et al. · New England Journal of Medicine · 2021 · 2.6K citations · Full text

, , +17

Ability of Recombinant Factor VIIa to Reverse the Anticoagulant Effect of the Pentasaccharide Fondaparinux in Healthy Volunteers

Nick R. Bijsterveld, Arno H. Moons, S. Matthijs Boekholdt et al. · Circulation · 2002 · 322 citations · Full text

, , +17

What does the HAMD mean?

Stefan Leucht, Hein Fennema, Rolf R. Engel et al. · Journal of Affective Disorders · 2013 · 206 citations

, , +1

Translating the HAM-D into the MADRS and vice versa with equipercentile linking

Stefan Leucht, Hein Fennema, Rolf R. Engel et al. · Journal of Affective Disorders · 2017 · 115 citations

, , +1

Recombinant factor VIIa reverses the anticoagulant effect of the long‐acting pentasaccharide idraparinux in healthy volunteers

Nick R. Bijsterveld, Roel Vink, Benien E. van Aken et al. · British Journal of Haematology · 2004 · 109 citations · Full text

, , +17

1–5 of 13